药物调控中性粒细胞胞外诱捕网逆转血栓性卒中tPA抵抗
本研究探讨药物调控中性粒细胞胞外诱捕网(NETs)能否逆转组织型纤溶酶原激活剂(tPA)抵抗,并分析Toll样受体4(TLR4)在血栓形成中的作用。采用小鼠光化学血栓性卒中模型及人类卒中患者血栓,发现DNase-I可溶解NETs并实现血管再通,而tPA无效;Cl-amidine预防性治疗完全阻止血栓性闭塞;血小板TLR4介导NETs形成;患者富血小板血栓可被DNase-I有效溶解。结论为调控NETs可促进富血小板血栓再通,克服tPA抵抗。
要点
- DNase-I溶解NETs可再通闭塞血管,改善光化学卒中结局,而tPA无效。
- Cl-amidine预防性抑制NETs形成可完全阻止血栓性闭塞。
- 血小板TLR4介导光化学卒中后NETs形成。
核心结论
- 药物调控NETs可溶解富血小板血栓,为克服卒中tPA抵抗提供新途径。
研究设计与样本
- 采用小鼠光化学血栓性卒中模型(产生富含聚集血小板的无纤维蛋白血栓)及人类卒中患者血栓进行实验研究。
主要发现
- DNase-I促进NETs溶解,可再通闭塞血管并改善光化学卒中结局,而tPA无此效果。
- 预防性给予Cl-amidine抑制NETs形成,完全阻止血栓性闭塞。
- 血小板TLR4介导光化学卒中后NETs形成。
- 离体新鲜富血小板血栓来自缺血性卒中患者,可被DNase-I有效溶解。
关键数值与推荐
- DNase-I可溶解来自缺血性卒中患者的离体新鲜富血小板血栓。
- Cl-amidine预防性治疗完全阻止光化学卒中模型中的血栓性闭塞。
临床怎么用
- 针对NETs的药物治疗可能成为tPA抵抗的富血小板血栓卒中的再通策略。
局限性
- 研究基于小鼠光化学血栓模型及离体患者血栓,尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Recanalization of the occluded artery is a primary goal in stroke treatment. Unfortunately, endovascular treatment is not always available, and tPA (tissue-type plasminogen activator) therapy is limited by its narrow therapeutic window; importantly, the rate of early arterial recanalization after tPA administration is low, especially for platelet-rich thrombi. The mechanisms for this tPA resistance are not well known. Since neutrophil extracellular traps (NETs) have been implicated in this setting, our aim was to study whether NET pharmacological modulation can reverse tPA resistance and the role of TLR4 (Toll-like receptor 4), previously related to NET formation, in thrombosis. Methods- To this goal, we have used a mouse photothrombotic stroke model, which produces a fibrin-free thrombus composed primarily of aggregated platelets and thrombi obtained from human stroke patients. Results- Our results demonstrate that (1) administration of DNase-I, which promotes NETs lysis, but not of tPA, recanalizes the occluded vessel improving photothrombotic stroke outcome; (2) a preventive treatment with Cl-amidine, impeding NET formation, completely precludes thrombotic occlusion; (3) platelet TLR4 mediates NET formation after photothrombotic stroke; and (4) ex vivo fresh platelet-rich thrombi from ischemic stroke patients are effectively lysed by DNase-I. Conclusions- Hence, our data open new avenues for recanalization of platelet-rich thrombi after stroke, especially to overcome tPA resistance.
引用
- Peña-Martínez C, Durán-Laforet V, García-Culebras A, et al. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance. Stroke. 2019. PMID: 31526124. doi:10.1161/STROKEAHA.119.026848
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。